针对患有严重抑郁症的成年人认知功能障碍的心理干预的最新进展:系统性审查
Maria-Alexandra Katsifi1, Elena Critselis1,2, Xanthi Tigani1
1Postgraduate Course on the Science of Stress and Health Promotion, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Advances in experimental medicine and biology
|November 22, 2025
概括
诸如认知补救疗法之类的心理干预措施,在患有严重抑郁症 (MDD) 的成年人中,有望改善注意力和日常功能. 然而,对执行功能和记忆的影响需要进一步研究.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 大型抑郁症 (MDD) 与持续的认知缺陷有关,包括注意力,执行功能,处理速度和记忆.
- 这些认知障碍会增加复发的风险,即使在情绪症状消失后.
- 正在探索心理干预作为MDD认知缺陷的非药物治疗方法.
研究的目的:
- 在过去十年中,系统地审查MDD成年人的认知缺陷心理干预的随机对照试验 (RCT).
- 评估认知补救疗法 (CRT) 和认知行为疗法 (CBT) 在改善认知功能的有效性.
主要方法:
- 在PubMed和Web of Science数据库 (2013年1月 - 2023年7月) 中进行了系统的文献搜索.
- 包括六个符合PRISMA指南的RCT,涉及干预组的187名参与者和对照组的125名参与者.
- 研究的重点是针对MDD认知障碍的CRT和CBT干预.
主要成果:
- 大多数研究报告说,注意力和自我评估的日常表现有显著改善.
- 执行功能,口头学习和记忆的结果是混合的,一些研究显示出显著的影响,而另一些则没有.
- 语言记忆,语言学习和执行功能的认知缺陷似乎对当前的干预措施最有抵抗力.
结论:
- 心理干预表明,对MDD中的特定认知领域,特别是注意力,有潜在的益处.
- 需要更大,更严格的设计,具有标准化措施的双盲RCT来确认疗效.
- 进一步的研究应该集中在针对口头记忆,口头学习和执行功能的持续缺陷的干预措施上.
相关概念视频
01:30Cognitive Development During Adulthood
752
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
752
01:25Cognitive Therapy
852
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
852
01:24Treatment Strategies for Psychological Disorders
672
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
672
01:27Depressive Disorders: MDD and Dysthymia
589
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
589
01:23Antidepressant Drugs: MAOIs and Other Agents
776
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
776
01:22Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772